Home/Pipeline/Peripheral Artery Disease Program

Peripheral Artery Disease Program

Peripheral Artery Disease

Pre-clinicalActive

Key Facts

Indication
Peripheral Artery Disease
Phase
Pre-clinical
Status
Active
Company

About Elixir Medical

Elixir Medical is an early-stage, private medical device company targeting the massive and underserved cardiovascular disease market. The company is developing transformative platforms for percutaneous coronary intervention (PCI) and peripheral interventions, aiming to address significant unmet needs such as high rates of adverse events and disease recurrence. While still in a pre-revenue, pre-clinical/development stage, Elixir positions itself as a disruptor seeking to reshape vascular medicine for decades to come by tackling problems where others have given up.

View full company profile

Other Peripheral Artery Disease Drugs

DrugCompanyPhase
Aperta NSE™ PTANipro MedicalCommercial
JTV-263Akros PharmaPhase1
Luminor DCBiVascularUPost-Market
iVolution pro StentiVascularUPost-Market
FGF-1Zhittya Genesis MedicinePhase 2
ChampioNIRMedinolInvestigational
Peripheral StentAdvanced BiomedApproved
Ranger DCBBoston ScientificPivotal Trial